Bjarnason et al. [26] reported that fluvastatin did not affect serum osteocalcin and serum and urinary CTX levels in postmenoposal women with osteoporosis and mild hypercholesterolemia when given in clinically relevant doses. Here, BGLAP is linked to osteoporosis.